Log in
Enquire now
Theragene Pharmaceuticals

Theragene Pharmaceuticals

Theragene Pharmaceuticals is an immunotherapy, gene therapy and peptide delivery.

OverviewStructured DataIssuesContributors

Contents

theragenepharma.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
Technology
Technology
Immunotherapy
Immunotherapy
Biotechnology
Biotechnology
Location
San Diego
San Diego
B2X
B2C
B2C
CEO
‌
Jon Berglin
Pitchbook URL
pitchbook.com/profiles.../92896-39
Legal Name
Theragene Pharmaceuticals, Inc.
Legal classification
Corporation
Corporation
Date Incorporated
2011
Number of Employees (Ranges)
1 – 10
Full Address
6150 Lusk Boulevard Suite B 201 San Diego, CA 92121 United States
Investors
Thynk Capital, LLC.
Thynk Capital, LLC.
Total Funding Amount (USD)
548,000
Latest Funding Round Date
December 2017
Latest Funding Type
Series A
Series A
Country
United States
United States

Other attributes

Company Operating Status
Active

Theragene Pharmaceuticals specializes in cancer and cardiology treatments. The company develops immunotherapy and Adeno-Associated Virus (AAV) gene therapy platforms.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Theragene Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us